Market Place
Sourcing Support
Psyence Biomed Closes $2.0 Million Private Placement
27 Dec 2024 //
GLOBENEWSWIRE
Psyence Biomedical Regains Nasdaq Compliance for Listing
23 Dec 2024 //
GLOBENEWSWIRE
Psyence Biomed Announces $2.0 Million Private Placement
23 Dec 2024 //
GLOBENEWSWIRE
Psyence Biomed Highlights Phase IIb Clinical Trial Progress
17 Dec 2024 //
GLOBENEWSWIRE
Psyence Biomed Signs Binding Agreements with Optimi Health Corp
10 Dec 2024 //
GLOBENEWSWIRE
Psyence Biomedical Issues Shareholder Update on Recent Progress
03 Dec 2024 //
GLOBENEWSWIRE
Psyence Bio Announces Favorable Nasdaq Listing Hearing Result
20 Nov 2024 //
GLOBENEWSWIRE
Psyence Biomedical Announces 1-for-75 Share Consolidation Date
19 Nov 2024 //
GLOBENEWSWIRE
Psyence Biomedical Announces AGM Results & Nasdaq Update
12 Nov 2024 //
GLOBENEWSWIRE
Psyence Group Closes Sale of Stake in PsyLabs
31 Oct 2024 //
GLOBENEWSWIRE
Psyence Biomedical Closes Acquisition of PsyLabs Stake
31 Oct 2024 //
GLOBENEWSWIRE
Psyence Biomed Adds Second Site For Psilocybin Trial
24 Oct 2024 //
GLOBENEWSWIRE
Psyence Provides Update On GMP Certified API Development
17 Oct 2024 //
GLOBENEWSWIRE
Psyence Group Enters Debt-For-Equity Swap With Psyence Biomedical
14 Oct 2024 //
GLOBENEWSWIRE
Psyence Biomed Provides Update On Acquisition Of Clairvoyant
04 Oct 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.